The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP

New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP

April 13, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Wendy Ramey, BSPharm, RPh, CSP

How are COVID-19 and physical distancing restrictions at work affecting rheumatology professionals? The Rheumatologist interviewed clinical pharmacist Wendy Ramey, BSPharm, RPh, CSP, to discuss how the pandemic has changed the way her staff supports rheumatologists at the University of Kentucky Specialty Pharmacy and Infusion Services, Lexington. Ms. Ramey describes how these unprecedented times affect patients, pharmacists and life outside the office.

You Might Also Like
  • How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD
  • Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP
  • The COVID-19 Pandemic & the ACR’s Response
Also By This Author
  • 2015 ACR/ARHP Annual Meeting: Research Offers Clues to Environmental Triggers of RA

Q: How are you and your staff adapting to restrictions related to the COVID-19 pandemic? Has your pharmacy changed its work routine to keep your staff safe?
The specialty pharmacy staff are ‘platooning.’ Most pharmacists and techs are working from home to set up refill shipments and assess patient adherence, outcomes and adverse effects of medications. We have our clinic-based pharmacists working from home reviewing lab reports, calling patients to discuss their regimens and what precautions to take. [They are also] supporting the rheumatologists, who are conducting patient visits via telemedicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The dispensing team is working in the pharmacy, trying to maintain a six-foot distance from each other. If the dispensing team needs help or someone becomes sick, then one of the platoons can come into the pharmacy to relieve that team member.

All meetings are now virtual. We continue to have our regular employee training [sessions], but they’re online. We have lost the ability to precept pharmacy students, who found alternate rotations in the hospital or in retail pharmacies, where they’re working with pharmacists on the front lines.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: How does the specialty pharmacy use technology to continue its work?
Because our staff is mostly working from home, it was necessary to set up VPNs [virtual private networks] for everyone, [ensuring everyone has] server access, desktops with dual monitors and soft phone service for access to the call center. This [approach] has forced us to be [mostly] paperless. We’re using a fax application to send and receive paperwork to each other, insurers and financial assistance programs. We also rely much more on electronic health records and updating information in the program instead of discussing cases verbally. These are all good practices anyway. I hope to continue many of these processes when we return to our regular environment.

Q: What are your patients’ chief concerns right now?
Patients are worried about running out of their medications. We have several shortages already, including hydroxychloroquine, but also sulfasalazine and sarilumab. Soon, we anticipate that tocilizumab will be hard to get.

Pages: 1 2 | Single Page

Filed Under: Practice Management Tagged With: coronavirus, COVID-19, Hydroxychloroquine (HCQ), Medication, pharmacist, sarilumab, Technology, telemedicine, tocilizumab

You Might Also Like:
  • How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD
  • Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP
  • The COVID-19 Pandemic & the ACR’s Response
  • A Collaborative Website as a Communication Model During the COVID-19 Pandemic

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.